UCHL1 and stroke disorder: In a randomized controlled trial investigating the effect of erythropoietin in acute ischemic stroke, a slight increase in UCHL1 during the first three days after stroke was noted in the placebo group but not in the treatment group; however, no imaging data was available [33].